A Novel Technique for Implanting Percutaneous Peripheral Neuromodulation Stimulators at the C2 Dorsal Root Ganglion for Managing Intractable Headaches: The Q2 Method
-
By
-
QiLiang Chen
-
Xiang Qian
-
November 9, 2024
Clinical Scorecard: A Novel Technique for Implanting Percutaneous Peripheral Neuromodulation Stimulators at the C2 Dorsal Root Ganglion for Managing Intractable Headaches: The Q2 Method
At a Glance
| Category | Detail |
|---|---|
| Condition | Intractable headache disorders including migraine and cluster headache refractory to medical therapies |
| Key Mechanisms | Modulation of the trigemino-cervical complex via peripheral neuromodulation targeting the C2 dorsal root ganglion (C2-DRG) |
| Target Population | Patients with intractable headaches unresponsive to multiple medication classes and invasive interventions |
| Care Setting | Outpatient setting under moderate sedation using combined ultrasound and fluoroscopic guidance |
Key Highlights
- The Q2 approach enables safe, minimally invasive percutaneous implantation of PNS electrodes at the C2-DRG in under 60 minutes.
- All 4 pilot patients achieved >50% pain relief during the 60-day implant period; 3 of 4 had sustained benefit beyond the implant period.
- No complications such as lead migration or infection were observed, demonstrating feasibility and safety in outpatient care.
Guideline-Based Recommendations
Diagnosis
- Identify patients with intractable headaches refractory to >3 classes of medications and >2 invasive interventions.
- Use clinical assessment to confirm headache distribution consistent with greater and lesser occipital nerve involvement.
Management
- Perform percutaneous C2-DRG PNS implantation using the Q2 approach under combined ultrasound and fluoroscopic guidance.
- Use intraoperative patient feedback to confirm electrode placement by eliciting concordant paresthesia in occipital nerve distributions.
- Administer prophylactic intravenous cefazolin prior to incision and maintain sterile technique.
Monitoring & Follow-up
- Conduct postoperative follow-ups at days 10, 30, 60, and 100–120 to assess pain relief and wound healing.
- Monitor for complications such as lead migration, infection, or adverse events related to neuromodulation.
Risks
- Potential mechanical injury to C2-DRG due to its anatomical location near epidural space, vertebral artery, and venous plexus.
- Risks minimized by ultrasound mapping of vascular structures and careful fluoroscopic guidance.
Patient & Prescribing Data
Four patients with intractable headaches refractory to multiple medications and prior invasive treatments.
All patients experienced significant pain relief (>50%) during the implant period; majority sustained benefit post-explantation without complications.
Clinical Best Practices
- Combine ultrasound and fluoroscopy to accurately identify C2-DRG and adjacent vascular anatomy before needle insertion.
- Use patient-reported paresthesia during implantation to optimize electrode positioning for effective stimulation.
- Perform the procedure under moderate sedation in an outpatient setting to reduce resource utilization and improve patient comfort.
- Educate patients on device operation including intensity adjustment via Bluetooth remote prior to discharge.
References
Based on findings from:
The Q2 approach for percutaneous peripheral neuromodulation stimulator implantation targeting the C2 dorsal root ganglion at the C2 lamina for treatment of intractable headache: a technical note
QiLiang Chen, Xiang Qian. Pain Medicine, 2024.
https://academic.oup.com/painmedicine/article/26/3/140/7888892
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
